Simplex Trading
TEVA icon

Simplex Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Simplex Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4M Buy
+643,000
New +$20.7M 0.01% 436
2025
Q4 		– Sell
-1,301,800
Closed -$26.3M – 10045
2025
Q3 		$26.3M Buy
1,301,800
+87,900
+7% +$1.54M 0.01% 534
2025
Q2 		$20.3M Sell
1,213,900
-547,900
-31% -$8.84M 0.01% 560
2025
Q1 		$27.1M Sell
1,761,800
-117,200
-6% -$2.09M 0.02% 425
2024
Q4 		$41.4M Buy
1,879,000
+87,900
+5% +$1.6M 0.02% 363
2024
Q3 		$32.3M Buy
1,791,100
+245,000
+16% +$4.29M 0.02% 444
2024
Q2 		$25.1M Buy
1,546,100
+460,800
+42% +$7.1M 0.02% 530
2024
Q1 		$15.3M Buy
1,085,300
+605,000
+126% +$7.63M 0.01% 868
2023
Q4 		$5.01M Sell
480,300
-827,700
-63% -$7.73M ﹤0.01% 1549
2023
Q3 		$13.3M Buy
1,308,000
+556,500
+74% +$5.18M 0.01% 789
2023
Q2 		$5.66M Buy
751,500
+235,800
+46% +$1.91M ﹤0.01% 1234
2023
Q1 		$4.56M Sell
515,700
-141,100
-21% -$1.4M ﹤0.01% 1357
2022
Q4 		$5.99M Sell
656,800
-225,500
-26% -$1.97M 0.01% 1124
2022
Q3 		$7.12M Sell
882,300
-425,000
-33% -$3.76M 0.01% 972
2022
Q2 		$9.83M Buy
1,307,300
+190,900
+17% +$1.66M 0.01% 797
2022
Q1 		$10.5M Sell
1,116,400
-776,000
-41% -$6.48M 0.01% 812
2021
Q4 		$15.2M Buy
1,892,400
+792,400
+72% +$7.15M 0.02% 609
2021
Q3 		$10.9M Buy
1,100,000
+6,300
+0.6% +$59K 0.01% 686
2021
Q2 		$10.8M Buy
1,093,700
+1,087,618
+17,883% +$11.5M 0.01% 683
2021
Q1 		$7.02M Buy
6,082
+350
+6% +$4.01K 0.01% 599
2020
Q4 		$5.53M Sell
5,732
-1,172
-17% -$11.2K 0.01% 922
2020
Q3 		$6.22M Sell
6,904
-6,338
-48% -$67K 0.01% 730
2020
Q2 		$16.3M Sell
13,242
-536
-4% -$6.06K 0.03% 359
2020
Q1 		$12.4M Buy
13,778
+5,157
+60% +$52.8K 0.02% 342
2019
Q4 		$8.45M Buy
8,621
+1,683
+24% +$15K 0.02% 530
2019
Q3 		$4.77M Buy
6,938
+2,028
+41% +$15.5K 0.01% 744
2019
Q2 		$4.53M Buy
4,910
+2,640
+116% +$31.8K 0.01% 735
2019
Q1 		$3.56M Sell
2,270
-4,790
-68% -$84.5K 0.01% 919
2018
Q4 		$10.9M Buy
7,060
+3,027
+75% +$62.1K 0.03% 317
2018
Q3 		$8.69M Buy
4,033
+689
+21% +$16K 0.03% 411
2018
Q2 		$8.13M Buy
3,344
+1,693
+103% +$34.5K 0.03% 401
2018
Q1 		$135K Sell
1,651
-3,659
-69% -$71.4K 0.01% 1555
2017
Q4 		$1.08M Buy
5,310
+102
+2% +$1.53K 0.05% 368
2017
Q3 		$214K Buy
5,208
+588
+13% +$13.2K 0.01% 1147
2017
Q2 		$691K Buy
4,620
+1,941
+72% +$60.1K 0.03% 507
2017
Q1 		$242K Sell
2,679
-1,412
-35% -$48.2K 0.01% 1097
2016
Q4 		$90K Buy
4,091
+1,525
+59% +$60.9K 0.01% 1624
2016
Q3 		$28K Sell
2,566
-8
-0.3% -$417 ﹤0.01% 2639
2016
Q2 		$115K Buy
2,574
+725
+39% +$38.6K 0.01% 1381
2016
Q1 		$108K Sell
1,849
-1,344
-42% -$78.9K 0.01% 1291
2015
Q4 		$846K Sell
3,193
-89
-3% -$5.5K 0.07% 258
2015
Q3 		$186K Buy
3,282
+1,649
+101% +$107K 0.01% 964
2015
Q2 		$226K Buy
1,633
+341
+26% +$21K 0.02% 744
2015
Q1 		$357K Buy
1,292
+989
+326% +$57.5K 0.04% 443
2014
Q4 		$216K Buy
+303
New +$16.9K 0.03% 562

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's TEVA Position: Q1 2026 in Review

Simplex Trading opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 11,315 shares worth $341K. The stake represents ﹤0.01% of the portfolio and ranks #3681 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TEVA as recently as Q3 2025.

Simplex Trading first reported a position in TEVA in Q4 2014 and has held it in 37 quarters since. The position peaked at $11.6M in Q4 2022. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Simplex Trading held 11,315 shares of Teva Pharmaceuticals worth $341K as of Q1 2026.
  • Teva Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3681 holding.
  • Simplex Trading first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 37 quarters since.
  • Simplex Trading's Teva Pharmaceuticals position peaked at $11.6M in Q4 2022.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.